E Holmén
Biographic Data
| ID | 7447034 |
|---|---|
| NAME | E Holmén |
| GIVEN NAMES | E |
| FAMILY NAME | Holmén |
| SIGNATURE | HOLMÉN E |
| AFFILIATIONS | Stockholm Health Care Services |
| ORCID | 0000-0002-2103-5611 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Needle and syringe coverage per injection and factors associated with needle sharing among clients of the Stockholm Needle and Syringe Program, 2013–2023
BACKGROUND: Needle and Syringe Programs (NSP) are a cornerstone of harm reduction, yet evidence on whether they adequately meet injection-related needs and reduce needle sharing in real-world settings, particularly where NSP were introduced late, remains limited. We examined needles to injection coverage and predictors of needle sharing among clients of the Stockholm NSP between 2013 and 2023. METHODS: Using data from a national clinical monitori…
Willingness and contextual considerations for supervised consumption sites
Our results suggest high SCS acceptability among a marginalised cohort of people who inject drugs in Stockholm. Results confirm and extend prior research by illuminating their perceptions, including important preferences to consider when designing a future SCS in Sweden
Take-Home Naloxone and risk management from the perspective of people who survived an opioid overdose in Stockholm — An analysis informed by drug, set and setting
The THN program has influenced "drug, set and setting" for participants, providing increased safety at drug-intake and transferring overdose management and the burden of care to the community. The lived experience of participants also exposes the limitations of THN indicating that there are additional unmet needs beyond THN programs, particularly in terms of "setting
A rapid assessment of take-home naloxone provision during Covid-19 in Europe
Through programme innovation supported by public guidelines, many European THN programmes managed to ensure stable or even increased THN provision during the pandemic, despite social distancing and stay-at-home orders affecting client mobility
No prominent works on this page.
A rapid assessment of take-home naloxone provision during Covid-19 in Europe
Through programme innovation supported by public guidelines, many European THN programmes managed to ensure stable or even increased THN provision during the pandemic, despite social distancing and stay-at-home orders affecting client mobility
Take-Home Naloxone and risk management from the perspective of people who survived an opioid overdose in Stockholm — An analysis informed by drug, set and setting
The THN program has influenced "drug, set and setting" for participants, providing increased safety at drug-intake and transferring overdose management and the burden of care to the community. The lived experience of participants also exposes the limitations of THN indicating that there are additional unmet needs beyond THN programs, particularly in terms of "setting
Willingness and contextual considerations for supervised consumption sites
Our results suggest high SCS acceptability among a marginalised cohort of people who inject drugs in Stockholm. Results confirm and extend prior research by illuminating their perceptions, including important preferences to consider when designing a future SCS in Sweden
Needle and syringe coverage per injection and factors associated with needle sharing among clients of the Stockholm Needle and Syringe Program, 2013–2023
BACKGROUND: Needle and Syringe Programs (NSP) are a cornerstone of harm reduction, yet evidence on whether they adequately meet injection-related needs and reduce needle sharing in real-world settings, particularly where NSP were introduced late, remains limited. We examined needles to injection coverage and predictors of needle sharing among clients of the Stockholm NSP between 2013 and 2023. METHODS: Using data from a national clinical monitori…
HIV, Drug Use, Sexual Risk (4 works) · Opioid Use Disorder Treatment (4 works) · Medicine (3 works) · Harm reduction (2 works) · Psychology (2 works) · Social Psychology (2 works) · Social Psychology (2 works) · Sociology (2 works) · Substance Abuse Treatment and Outcomes (2 works) · Business (1 works)